The global Lapatinib Market is poised for significant expansion, driven by increasing prevalence of breast cancer and advancements in targeted therapy. Lapatinib, a tyrosine kinase inhibitor, plays a crucial role in treating HER2-positive breast cancer by blocking cancer cell growth signals.